A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/57 (2006.01) A61K 38/30 (2006.01) A61P 35/00 (2006.01) C07K 14/65 (2006.01) C07K 14/81 (2006.01) C12N 9/64 (2006.01)
Patent
CA 2659585
Insulin-like growth factor binding proteins (IGFBPs) and variants thereof, including IGFBP-1, IGFBP-2, IGFBP-3, IGFBP-4, IGFBP-5, IGFBP-6 and the C-terminal fragments thereof, inhibit angiogenesis, tumorigenesis and cathepsin activity, particularly cathepsin B activity.
La présente invention concerne des protéines de liaison au facteur de croissance de type insuline (IGFBP) et des variants de celles-ci, comprenant IGFBP-1, IGFBP-2, IGFBP-3, IGFBP-4, IGFBP-5, IGFBP-6 et leurs fragments C-terminal, qui inhibent l'angiogenèse, la tumorigenèse et l'activité de la cathepsine, notamment l'activité de la cathepsine B.
Ball Marquerite
Durocher Yves
Moreno Maria J.
Stanimirovic Danica B.
Battison Williams Dupuis
National Research Council Of Canada
LandOfFree
Inhibition of angiogenesis, tumorigenesis and cathepsin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of angiogenesis, tumorigenesis and cathepsin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of angiogenesis, tumorigenesis and cathepsin... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1425671